Zurex Pharma, Inc.: Clinical Trials

9 trials sponsored by Zurex Pharma, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 terminated. 5 Phase 3, 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 12Completed 2
Phase 22Completed 1, Terminated 1

Follow Zurex Pharma, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perioperative Patient Skin Antiseptic Preparation Evaluation
70% v/v Isopropyl Alcohol Surgical Solution, 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol - Surgical Site Infection
Phase 3CompletedZurex Pharma, Inc.512021-06-212024-03-20
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
ZuraPrep Clear Solution, ChloraPrep, ZuraPrep Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.1562019-01-252023-02-08
Clinical Evaluation of Patient Preoperative Prep
ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.6402016-08-032021-07-16
In-vivo Efficacy of Patient Preoperative Prep
ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.4402016-07-272023-02-08
Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle
ZuraPrep with 70% IPA, ZuraPrep without 70% IPA, ChloraPrep CHG/IPA Teal Tint - Surgical Site Infection
Phase 3CompletedZurex Pharma, Inc.1232015-10-012017-07-17
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)
ZuraPrep, ChloraPrep - Surgical Site Infection
Phase 2CompletedZurex Pharma, Inc.362014-11-012016-07-14
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™
Chloraprep, ZuraPrep, ZuraPrep Vehicle - Surgical Site Infection
Phase 2TerminatedZurex Pharma, Inc.642014-08-012016-07-18
Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
Chloraprep, 0.9% Physiological Saline, ZuraPrep without IPA - Surgical Site Infection
Phase 1CompletedZurex Pharma, Inc.2082014-07-012015-03-17
Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
ChloraPrep, 0.1% Sodium Lauryl Sulfate, 0.9% Physiological Saline - Surgical Site Infection
Phase 1CompletedZurex Pharma, Inc.402014-06-012014-10-27

Conditions studied

Surgical Wound Infection (6)

Interventions

citrate, isopropyl alcohol, methylene blue, parabens drug combination (8)  ·  Ethanol (7)  ·  chlorhexidine gluconate (7)  ·  Chromogranins (6)  ·  2-Propanol (2)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Sodium Dodecyl Sulfate (1)

Countries

United States (9)

Top investigators

Chris Beausoleil (1)  ·  Esther Campbell (1)  ·  Joseph P Hart, MD, FACS, DFSVS (1)  ·  M H Bashir, MD (1)  ·  M. Hamid Barshir, MD (1)  ·  M. Hamid Bashir, MD (1)  ·  Maggie Butler, PhD (1)  ·  Muhammad H Bashir (1)

Results publications

PMID 32131912